| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/21/2005 | CA2541667A1 Substituted pyrazinone compounds for the treatment of inflammation |
| 04/21/2005 | CA2541582A1 Indoles and azaindoles as antiviral agents |
| 04/21/2005 | CA2541162A1 Fused lactam compounds |
| 04/21/2005 | CA2540868A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 04/21/2005 | CA2540867A1 Process for the preparation of n-amino substituted heterocyclic compounds |
| 04/21/2005 | CA2539882A1 Substituted isoquinolinones |
| 04/21/2005 | CA2526017A1 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/20/2005 | EP1524272A1 Growth hormone secretagogues |
| 04/20/2005 | EP1524265A1 Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors |
| 04/20/2005 | EP1523481A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 04/20/2005 | EP1523480A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 04/20/2005 | EP1523473A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 04/20/2005 | EP1523313A1 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4- 1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
| 04/20/2005 | EP1448547B1 Pyridine derivatives as nmda receptor ligands |
| 04/20/2005 | EP1443934B1 Benzotriazepines as gastrin and cholecystokinin receptor ligands |
| 04/20/2005 | EP1373249B1 Imidazolidine derivatives, their preparation, and their use as antiinflamatory agent |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1254133B1 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1200414B1 Process for the preparation of substituted pyrimidines |
| 04/20/2005 | EP1177185B1 4, 5, 6, 7-tetrahydroindazole derivatives as antitumor agents |
| 04/20/2005 | EP1140904B1 Farnesyl protein transferase inhibitors |
| 04/20/2005 | EP1042287B1 Indole derivatives as inhibitors of factor xa |
| 04/20/2005 | EP1029851B1 Piperazine compounds and medicinal use thereof |
| 04/20/2005 | EP1015431B1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 04/20/2005 | EP0766669B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/20/2005 | EP0721455B9 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 04/20/2005 | CN1608063A Indolinone derivatives |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1608061A Therapeutic isoquinoline compounds |
| 04/20/2005 | CN1608060A Diaryl 1, 2, 4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1608059A Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1608053A Heterocyclic derivatives of glycinamide and its pharmaceutical uses |
| 04/20/2005 | CN1607951A Quinoline derivatives as neuropeptide y antagonists |
| 04/20/2005 | CN1197861C Method for preparing solid optical pure neutral S- (-) - and (R) - (+) -Omeprazole |
| 04/20/2005 | CN1197860C FAB I inhibitors |
| 04/20/2005 | CN1197859C Febrifugine and isofebrifugine and processes for the preparation of both |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197574C Method for stabilizing benzimidazole compounds |
| 04/19/2005 | US6881848 Process for preparing 4-trifluoromethylsulfinylpyrazole derivative |
| 04/19/2005 | US6881844 Indole-3-carboxamides as glucokinase activators |
| 04/19/2005 | US6881815 Comprises polymerization catalysts; aromatization; elminates need for nitration |
| 04/19/2005 | US6881753 Potassium channel inhibitors and method |
| 04/19/2005 | US6881747 Small molecules for inhibition of function and drug delivery to leukocytes |
| 04/19/2005 | US6881743 Pyridine matrix metalloproteinase inhibitors |
| 04/19/2005 | US6881740 Pharmaceutical agents |
| 04/19/2005 | US6881738 Analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders |
| 04/19/2005 | US6881737 Substituted triazinyl acrylamide derivatives and methods of use |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881536 Particle based electrochemiluminescent assays |
| 04/19/2005 | CA2315189C Integrin receptor antagonists |
| 04/19/2005 | CA2273894C Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 04/19/2005 | CA2172162C Optically active imidazolidinone derivative and process for producing the same |
| 04/19/2005 | CA2116631C Process for the preparation of aqueous nicotinaldehyde |
| 04/14/2005 | WO2005033108A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 04/14/2005 | WO2005033106A1 Azolidinecarbonitriles and their use as dpp-iv inhibitors |
| 04/14/2005 | WO2005033105A2 Vanilloid receptor ligands and their use in treatments |
| 04/14/2005 | WO2005033097A1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 04/14/2005 | WO2005033096A1 Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof |
| 04/14/2005 | WO2005033095A1 Fungicidal 4-(2-aminopyridin-4-yl)-n-phenyl-1,3,5-triazin-2-amine derivatives |
| 04/14/2005 | WO2005033081A1 4-piridinylmethylsulphonamide derivatives as fungicidal plant protection agents |
| 04/14/2005 | WO2005033073A2 Spirocyclic heterocyclic derivatives and methods of their use |
| 04/14/2005 | WO2005033048A2 Wnt pathway antagonists |
| 04/14/2005 | WO2005032548A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/14/2005 | WO2005032547A1 Bicyclo`3.1.1!heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
| 04/14/2005 | WO2005032493A2 Amide compounds as ion channel ligands and uses thereof |
| 04/14/2005 | WO2005032490A2 Cyclic diamines and derivatives as factor xa inhibitors |
| 04/14/2005 | WO2005032484A2 Alkoxy substituted imidazoquinolines |
| 04/14/2005 | WO2005032472A2 Pyrrolidine and piperidine derivatives as factor xa inhibitors |
| 04/14/2005 | WO2005016883A3 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| 04/14/2005 | WO2005014723A8 Cyanin-type compounds having an alkynyl linker arm |
| 04/14/2005 | WO2005007111A3 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/14/2005 | WO2005002503A3 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 04/14/2005 | WO2005000281A3 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 04/14/2005 | WO2004099154A3 Pyrazole-amides and sulfonamides as sodium channel modulators |
| 04/14/2005 | WO2004092124A3 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 04/14/2005 | WO2004091542A3 Nitrogen containing integrin targeting compounds |
| 04/14/2005 | US20050080272 Halogenated nitrobutadienes for controlling animal pests |
| 04/14/2005 | US20050080271 Peptidomimetic ligands for cellular receptors and ion channels |
| 04/14/2005 | US20050080265 Sleep disorders; side effect reduction |
| 04/14/2005 | US20050080258 Kinase inhibitors; autoimmune disease; antiinflammatory agents |
| 04/14/2005 | US20050080129 Derivatives of andrimide and moiramide b having antibacterial properties |
| 04/14/2005 | US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080111 Antagonists of liver X receptors; control of cholesterol, triglyceride, or bile acid levels; 6-(1-Benzyl-1H-pyrazol-4-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile |
| 04/14/2005 | US20050080108 such as (S)-1-ethyl-5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid-[2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]amide; for treatment of obesity and lipid disorders; diabetes |
| 04/14/2005 | US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 04/14/2005 | US20050080101 N-[4-(pyrazolyl)-pyrimidin-2-yl]-N-phenyl-amine derivatives |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080095 Novel amides useful for treating pain |
| 04/14/2005 | US20050080090 Such as 7-(Imidazolo[4,5-b]pyridin-1-yl)-1-(1-methylpyrrolidin-3-yl)naphthalene; for treating depression, anxiety, eating disorders, drug abuse, cluster headache, migraine, pain, and other disorders arising from deficient serotonergic neurotransmission |
| 04/14/2005 | US20050080087 For treatment of metabolic disorders, eating disorders, appetitive disorders, psychiatric disorders, memory impairment, Parkinson's disease, Alzheimer's disease, substance abuse, leukocyte activation-associated disorders, and inflammatory diseases |
| 04/14/2005 | US20050080082 Potassium channel modulators |
| 04/14/2005 | US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | DE19842833B4 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung 2-arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole and 2-Arylalkinylthio-imidazoles as inflammatory inhibitors and inhibitors of cytokine release |
| 04/14/2005 | DE10343098A1 Tetrahydrochinoxaline und ihre Verwendung Tetrahydroquinoxalines and their use |
| 04/14/2005 | DE10342503A1 Benzyl-Benzimidazolylderivate Benzyl-Benzimidazolylderivate |
| 04/14/2005 | CA2541299A1 Amide compounds as ion channel ligands and uses thereof |